Urinary versus recombinant gonadotropins for ovarian stimulation in women undergoing treatment with assisted reproductive technology

• Main Authors: Ameet Patki (Author), Himanshu Bavishi (Author), Chandravati Kumari (Author), Jayarani Kamraj (Author), M Venugopal (Author), K U Kunjimoideen (Author), Poornima Nadkarni (Author), Samundi Sankari (Author), Sunil Chaudhary (Author), M J Sangeeta (Author), C S Manjunath (Author), Pratap Kumar (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2018-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Globally, about 10%-15% couples are affected by infertility, with major role being played by the couple's lifestyle. Several gonadotropin preparations (urinary, purified urinary, recombinant, and biosimilars) are available for use. Purified urinary formulations offer numerous advantages over th...